Yu Xue

12 Wulumuqizhong Road, 200040
Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Efficacy and Safety of Firsekibart in Patients with Acute Gout Unsuitable for Standard Therapy: 48-Week Results from an Open-Label Extension of a Randomized Phase 3 Trial.

Efficacy and Safety of Firsekibart in Patients with Acute Gout Unsuitable for Standard Therapy: 48-Week Results from an Open-Label Extension of a Randomized Phase 3 Trial.

Journal: Advances in therapy

Published: February 13, 2026

SSGJ-613 Alleviates Pain and Reduces the Risk of Acute Flares in Patients With Gout: A Randomized, Double-Blind, Phase II Study.

SSGJ-613 Alleviates Pain and Reduces the Risk of Acute Flares in Patients With Gout: A Randomized, Double-Blind, Phase II Study.

Journal: International journal of rheumatic diseases

Published: December 30, 2025

CCR2-Guided Treg Exosome-Gas6 Hybrid Synergistically Reprograms Macrophage Inflammation and Immune Tolerance in Gouty Arthritis.

CCR2-Guided Treg Exosome-Gas6 Hybrid Synergistically Reprograms Macrophage Inflammation and Immune Tolerance in Gouty Arthritis.

Journal: Advanced healthcare materials

Published: December 03, 2025

Firsekibart versus compound betamethasone in acute gout patients unsuitable for standard therapy: A randomized phase 3 trial.

Firsekibart versus compound betamethasone in acute gout patients unsuitable for standard therapy: A randomized phase 3 trial.

Journal: Innovation (Cambridge (Mass.))

Published: April 20, 2025

In situ sustained and pH-responsive Gas6-loaded microspheres for alleviating acute gouty arthritis by immunoregulation.

In situ sustained and pH-responsive Gas6-loaded microspheres for alleviating acute gouty arthritis by immunoregulation.

Journal: Colloids and surfaces. B, Biointerfaces

Published: March 07, 2025

Firsekibart in acute gouty arthritis.

Firsekibart in acute gouty arthritis.

Journal: Journal of translational medicine

Published: January 03, 2025

Anti-inflammatory effects of MerTK by inducing M2 macrophage polarization via PI3K/Akt/GSK-3β pathway in gout.

Anti-inflammatory effects of MerTK by inducing M2 macrophage polarization via PI3K/Akt/GSK-3β pathway in gout.

Journal: International immunopharmacology

Published: April 09, 2024

The application of a novel hydrodynamic cavitation device to debride intra-articular monosodium urate crystals.

The application of a novel hydrodynamic cavitation device to debride intra-articular monosodium urate crystals.

Journal: BMC surgery

Published: June 17, 2022

Recent Insights Into the Role of Macrophages in Acute Gout.

Recent Insights Into the Role of Macrophages in Acute Gout.

Journal: Frontiers in immunology

Published: May 29, 2022

Type II collagen facilitates gouty arthritis by regulating MSU crystallisation and inflammatory cell recruitment.

Type II collagen facilitates gouty arthritis by regulating MSU crystallisation and inflammatory cell recruitment.

Journal: Annals of the rheumatic diseases

Published: May 06, 2022

Neutrophil Extracellular Trap-Borne Elastase Prevents Inflammatory Relapse in Intercritical Gout.

Neutrophil Extracellular Trap-Borne Elastase Prevents Inflammatory Relapse in Intercritical Gout.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: April 19, 2022

Inflammatory Response to Regulated Cell Death in Gout and Its Functional Implications.

Inflammatory Response to Regulated Cell Death in Gout and Its Functional Implications.

Journal: Frontiers in immunology

Published: March 02, 2022

Showing 1-12 of 23

Last Updated: 09/26/2026